👤 Chunpeng Pan

🔍 Search 📋 Browse 🏷️ Tags ❤️ Favourites ➕ Add 🧬 Extraction
394
Articles
300
Name variants
Also published as: Alan P Pan, Allen L Pan, Anni Pan, Bao-Long Pan, Bei Pan, Beibin Pan, Bin Pan, Bo Pan, Bo-Yi Pan, Calvin Pan, Chaomin Pan, Chen-Wen Pan, Chengfu Pan, Chengliang Pan, Chenxi Pan, Cheol-Ho Pan, Chi-Jiunn Pan, Chien-Hsiung Pan, Chih-Chuan Pan, Chin-Chen Pan, Ching-Chian Pan, Chongge Pan, Chuanying Pan, Chunyu Pan, Cuili Pan, Cuiping Pan, Cuizhen Pan, Dan Pan, Daodong Pan, David Z Pan, De-Biao Pan, De-Si Pan, Defeng Pan, Dejing Pan, Deng Pan, Deyu Pan, Dikang Pan, Dongmei Pan, Duojia Pan, Edward Pan, Fan Pan, Feng Pan, Gang Pan, Guangxin Pan, Guo-zhong Pan, Hai-Feng Pan, Haibang Pan, Haitao Pan, Haiyan Pan, Haizhou Pan, Hanghai Pan, Hao Pan, Haobo Pan, Hehai Pan, Hejing Pan, Henan Pan, Heng Pan, Hong Pan, Hong-Wei Pan, Hongbin Pan, Hongmei Pan, Hongming Pan, Hongxu Pan, Hongyuan Pan, Huafeng Pan, Hui Pan, Hui-Ping Pan, Huichao Pan, Hung-Chuan Pan, Jia Pan, Jia-Xiang Pan, Jiajie Pan, Jialin Pan, Jian Pan, Jian'an Pan, Jiandong Pan, Jianfeng Pan, Jianxin Pan, Jiaren Pan, Jiaxing Pan, Jie Pan, Jie-Li Pan, Jincheng Pan, Jing Pan, Jingye Pan, Jinyu Pan, Jiongwei Pan, Jirong Pan, Juan Pan, Jun Pan, Jun-Jie Pan, Junfan Pan, Junping Pan, Kai Pan, Kai-Feng Pan, Kaixin Pan, Ke Pan, Kejian Pan, Kuo-Li Pan, Kylie S Pan, Lei Pan, Li Pan, Li-Hua Pan, Liangbin Pan, Liangxuan Pan, Lijuan Pan, Liming Pan, Lina Pan, Ling-Ai Pan, Lingling Pan, Linqing Pan, Liuliu Pan, Liying Pan, Lu Pan, Luqing Pan, Manyi Pan, Mei Pan, Mei-Hung Pan, Meihui Pan, Meijun Pan, Meimei Pan, Meng Pan, Menghao Pan, Mengru Pan, Mengshan Pan, Mengxia Pan, Mengxue Pan, Mengyu Pan, Min Pan, Min-Hsiung Pan, Ming Pan, Minghong Pan, Mingjie Pan, Mingxia Pan, Mu-Su Pan, Pan Pan, Pauline Lining Pan, Peijiang Pan, Peipei Pan, Peng Pan, Ping Pan, Q Pan, Q R Pan, Qi Pan, Qian Pan, Qianqian Pan, Qiaoling Pan, Qin Pan, Qini Pan, Qiong Pan, Qiu-Ling Pan, Qiuhui Pan, Qiuling Pan, Qiuwei Pan, Ruize Pan, Shang-Ling Pan, Shanshan Pan, Sheng Pan, Shengying Pan, Shien-Tung Pan, Shifeng Pan, Shilei Pan, Shou Pan, Shu-Ming Pan, Shuya Pan, Shuyi Pan, Simiao Pan, Sipei Pan, Siwei Pan, Stephen Pan, T Pan, Tai-Long Pan, Tam In Pan, Tao Pan, Ting Pan, Ting-Ting Pan, Tingli Pan, Tingting Pan, Wang Pan, Warren Pan, Wei Pan, Wen Pan, Wen-Harn Pan, Wenhao Pan, Wenjing Pan, Wensheng Pan, Wenwei Pan, Wenzhi Pan, Wilbur Pan, X Pan, Xiangbin Pan, Xiao Pan, Xiao-Fu Pan, Xiao-Xia Pan, Xiao-hua Pan, Xiaohong Pan, Xiaomin Pan, Xiaona Pan, Xiaoqiong Pan, Xiaorong Pan, Xiaowen Pan, Xiaoxia Pan, Xiaoying Pan, Xiaoyue Pan, Xin Pan, Xinghua Pan, Xingxi Pan, Xingxiu Pan, Xingyan Pan, Xinming Pan, Xinyun Pan, Xiong-Fei Pan, Xiucheng Pan, Xiuhua Pan, Xiuyi Pan, Xuan Pan, Xue Pan, Xuebo Pan, Xuefang Pan, Xuehua Pan, Xueliang Pan, Y Pan, Y X Pan, Y Z Pan, Ya-Qiang Pan, Ya-Xiong Pan, Yan Pan, Yan-Jun Pan, Yanan Pan, Yanchang Pan, Yanchao Pan, Yanfei Pan, Yang Pan, Yangyang Pan, Yanmeng Pan, Yanpei Pan, Yaoxin Pan, Yaping Pan, Ye Pan, Yen-Ting Pan, Yi Pan, Yifan Pan, Yifeng Pan, Yihan Pan, Yihang Pan, Yihui Pan, Yijun Pan, Ying Pan, Ying-Hua Pan, Ying-Ni Pan, Ying-Ru Pan, Yinghong Pan, Yingtian Pan, Yingzi Pan, Yitao Pan, Yong Pan, Yong-Quan Pan, Yongchu Pan, Yongjie Pan, Yu Pan, Yu-Jia Pan, Yuan Pan, Yuan-Xiang Pan, Yuancan Pan, Yuancheng Pan, Yuchen Pan, Yuchun C Pan, Yuchun Pan, Yue Pan, Yuesong Pan, Yueyin Pan, Yunbing Pan, Yuqin Pan, Yuting Pan, Yuwen Pan, Z M Pan, Zaixu Pan, Zengkai Pan, Zhang-Yi Pan, Zhangyuan Pan, Zhe Pan, Zhen Pan, Zhenhua Pan, Zhi-Yuan Pan, Zhi-Zhong Pan, Zhijun Pan, Zhisen Pan, Zhiyong Pan, Zhuoyue Pan, Zihao Pan, Zihong Pan, Zimeng Pan, Ziqiang Pan, Ziwei Pan, Ziwen Pan, Zixiang Pan, Ziyi Pan, Ziyue Pan, Zonghao Pan
articles
Guo-zhong Pan, Wen-ling Liu, Da-Yi Hu +5 more · 2006 · Zhonghua yi xue za zhi · added 2026-04-24
To compare the gene mutation between Chinese patients with familial and sporadic hypertrophic cardiomyopathy (HCM). Peripheral blood samples were collected from 36 patients with familial HCM (FHCM) an Show more
To compare the gene mutation between Chinese patients with familial and sporadic hypertrophic cardiomyopathy (HCM). Peripheral blood samples were collected from 36 patients with familial HCM (FHCM) and 50 patients with sporadic HCM (SHCM), all un-related and from different provinces of China. PCR was used to amplify the 26 protein-coding axons of beta-myosin heavy chain (MYH7), 16 exons for cardiac troponin T (TNNT2), and 38 exons for cardiac myosin-binding protein C (MYBPC3). The amplified products were sequenced and compared with the standard sequence in the genBank so as to determine the potential mutation sites. (1) 13 of the 36 FHCM patients (36.1%) harbored 3 different mutations in MYH7 gene: Arg663His in exon18, Glu924Lys in exon 23, and Ile736Thr in exon 20. Of the 50 SHCM patients, only 1 (2%) harbored MYH7 gene missence mutation: Ile736Thr located in exon 20. (2) TNNT2 was not identified in all SHCM patients and FHCM patients. (3) MYBPC3 was not identified in all SHCM patients. Four FHCM patients harbored 2 different mutations: Arg502Trp in exon 18 and Arg346fs in exon 13 respectively. MYH7 and MYBPC3 may be the dominant disease-causing genes in Chinese familial HCM patients; however the mutation rate of MYH7 and MYBPC3 genes is significantly lower in the SHCM patients compared with the FHCM patients. TNNT2 seems not the predominant disease-causing gene in all Chinese patients with HCM. Show less
no PDF
MYBPC3
Andrew D Nguyen, Chi-Jiunn Pan, Jeng-Jer Shieh +1 more · 2005 · FEBS letters · Elsevier · added 2026-04-24
Glycogen storage disease type Ia (GSD-Ia) patients manifest a pro-atherogenic lipid profile but are not at elevated risk for developing atherosclerosis. Serum phospholipid, which correlates positively Show more
Glycogen storage disease type Ia (GSD-Ia) patients manifest a pro-atherogenic lipid profile but are not at elevated risk for developing atherosclerosis. Serum phospholipid, which correlates positively with the scavenger receptor class B type I (SR-BI)-mediated cholesterol efflux, and apolipoprotein A-IV and E, acceptors for ATP-binding cassette transporter A1 (ABCA1)-mediated cholesterol transport, are increased in GSD-Ia mice. Importantly, sera from GSD-Ia mice are more efficient than sera from control littermates in promoting SR-BI- and ABCA1-mediated cholesterol effluxes. As the first step in reverse cholesterol transport, essential for cholesterol homeostasis, these observations provide one explanation why GSD-Ia patients are apparently protected against premature atherosclerosis. Show less
no PDF DOI: 10.1016/j.febslet.2005.07.042
APOA4
J D Loeb, T A Kerentseva, T Pan +2 more · 1999 · Genetics · Oxford University Press · added 2026-04-24
Several lines of evidence suggest that the morphogenetic transition from the yeast form to pseudohyphae in Saccharomyces cerevisiae may be regulated by the cyclin-dependent kinase (Cdk). To examine th Show more
Several lines of evidence suggest that the morphogenetic transition from the yeast form to pseudohyphae in Saccharomyces cerevisiae may be regulated by the cyclin-dependent kinase (Cdk). To examine this hypothesis, we mutated all of the G1 cyclin genes in strains competent to form pseudohyphae. Interestingly, mutation of each G1 cyclin results in a different filamentation phenotype, varying from a significant defect in cln1/cln1 strains to enhancement of filament production in cln3/cln3 strains. cln1 cln2 double mutants are more defective in pseudohyphal development and haploid invasive growth than cln1 strains. FLO11 transcription, which correlates with the level of invasive growth, is low in cln1 cln2 mutants and high in grr1 cells (defective in proteolysis of Cln1,2), suggesting that Cln1,2/Cdks regulate the pseudohyphal transcriptional program. Epistasis analysis reveals that Cln1,2/Cdk and the filamentation MAP kinase pathway function in parallel in regulating filamentous and invasive growth. Cln1 and Cln2, but not Ste20 or Ste12, are responsible for most of the elevated FLO11 transcription in grr1 strains. Furthermore, phenotypic comparison of various filamentation mutants illustrates that cell elongation and invasion/cell-cell adhesion during filamentation are separable processes controlled by the pseudohyphal transcriptional program. Potential targets for G1 cyclin/Cdks during filamentous growth are discussed. Show less
no PDF DOI: 10.1093/genetics/153.4.1535
CLN3
L Xu, J Xia, H Jiang +7 more · 1999 · Human genetics · Springer · added 2026-04-24
Hereditary multiple exostoses (EXT; MIM 133700) is an autosomal dominant bone disorder. It is genetically heterogeneous with at least three chromosomal loci: EXT1 on 8q24.1, EXT2 on 11p11, and EXT3 on Show more
Hereditary multiple exostoses (EXT; MIM 133700) is an autosomal dominant bone disorder. It is genetically heterogeneous with at least three chromosomal loci: EXT1 on 8q24.1, EXT2 on 11p11, and EXT3 on 19p. EXT1 and EXT2, the two genes responsible for EXT1 and EXT2, respectively, have been cloned. Recently, three other members of the EXT gene family, named the EXT-like genes (EXTL: EXTL1, EXTL2, and EXTL3), have been isolated. EXT1, EXT2, and the three EXTLs are homologous with one another. We have identified the intron-exon boundaries of EXTL1 and EXTL3 and analyzed EXT1, EXT2, EXTL1, and EXTL3, in 36 Chinese families with EXT, to identify underlying disease-related mutations in the Chinese population. Of the 36 families, five and 12 family groups have mutations in EXT1 and EXT2, respectively. No disease-related mutation has been found in either EXTL1 or EXTL2, although one polymorphism has been detected in EXTL1. Of the 15 different mutations (three families share a common mutation in EXT2), 12 are novel. Most of the mutations are either frameshift or nonsense mutations (12/15). These mutations lead directly or indirectly to premature stop codons, and the mutations generate truncated proteins. This finding is consistent with the hypothesis that the development of EXT is mainly attributable to loss of gene function. Missense mutations are rare in our families, but these mutations may reflect some functionally crucial regions of these proteins. EXT1 is the most frequent single cause of EXT in the Caucasian population in Europe and North America. It accounts for about 40% of cases of EXT. Our study of 36 EXT Chinese families has found that EXT1 seems much less common in the Chinese population, although the frequency of the EXT2 mutation is similar in the Caucasian and Chinese populations. Our findings suggest a possibly different genetic spectrum of this disease in different populations. Show less
no PDF DOI: 10.1007/s004399900058
EXT1